Colgate-Palmolive (NYSE: CL) reported Q4 EPS of $0.77, $0.01 better than the analyst estimate of $0.76. Revenue for the quarter came in at $4.32 billion versus the consensus estimate of $4.14 billion.

Full Year 2021 Guidance:

Based on current spot rates:

• The Company expects net sales to be up 4% to 7% including a low-single-digit benefit from foreign exchange.
• The Company expects organic sales to be up within its long-term targeted range of 3% to 5%.
• On a GAAP basis, the Company expects gross margin expansion, increased advertising investment and low to mid-single-digit earnings-per-share growth.
• On a non-GAAP (Base Business) basis, the Company expects gross margin expansion, increased advertising investment and mid to high-single-digit earnings-per-share growth.

For earnings history and earnings-related data on Colgate-Palmolive (CL) click here.